Clinical Trial Update: Efficacy and Safety of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Acute Rhinosinusitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated the efficacy and safety of the herbal medicinal product BNO 1016 for acute rhinosinusitis, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• BNO 1016

Snippet

Sponsor: Bionorica SE | Conditions: Acute Rhinosinusitis | Phase 3 | Status: COMPLETED | Results posted: 2013-08-02